Novan, inc. (NOVN)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
Cash flow from operating activities:
Net loss

-6,167

3,082

-8,336

-18,486

-6,637

-9,413

-7,031

-7,578

-5,217

-8,072

-7,327

-9,839

-11,383

-13,061

-17,474

-17,904

-11,260

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, Depletion and Amortization

495

502

510

518

503

430

425

408

401

393

391

340

299

182

187

202

186

Share-based compensation

272

-606

690

1,540

214

301

470

546

887

752

871

883

1,252

712

327

307

227

Loss on disposal and write-offs of property and equipment

-44

-

-4

-32

0

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal and write-offs of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

34

0

0

2

Changes in operating assets and liabilities:
Fair Value Adjustment of Warrants

-

-

-

-

-

-

-1,464

-711

-3,558

-

-

-

-

-

-

-

-

Contracts and grants receivable

-230

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-125

563

-255

175

-45

524

8

-314

6

413

-159

-400

71

501

-440

-182

143

Accounts payable

-692

-893

1,538

-535

242

864

-654

214

353

-446

-439

-616

-1,022

-810

2,471

506

-795

Accrued compensation

670

-1,070

95

-670

615

-222

309

403

-1,191

-27

188

399

-697

409

410

431

8

Accrued outside research and development services

915

-369

593

-28

254

-1,008

163

150

-134

216

-646

-893

-3,022

-4,140

3,656

3,409

1,724

Accrued legal and professional fees

-508

448

-127

37

-199

193

38

-166

67

100

-161

-332

390

176

101

-151

53

Other accrued expenses

-52

-380

221

168

-406

-152

26

132

-621

-

-

-

-

-

-

-

-

Deferred revenue

-1,143

3,378

-1,100

-1,101

3,360

372

-648

-689

-645

-

-

-

-

-

-

-

-

Research and development service obligation liabilities

-1,513

-2,642

-3,350

-2,193

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

96

522

-416

186

791

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-646

10,489

-

-

-

-

Other long-term assets and liabilities

114

-

112

113

101

-

-15

-15

-16

-

-

-

-

-

-

-

-

Other long-term assets and liabilities

-

-

-

-

-

-

-

-

-

-

-

-

295

0

7

10

8

Net cash used in continuing operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,545

-10,305

-12,842

-9,219

Net cash used in discontinued operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

-258

Net cash used in operating activities

-7,438

-8,455

-10,495

1,184

-2,110

-3,749

-8,359

-6,869

-9,648

-7,965

-7,462

-10,466

-3,964

-16,545

-10,305

-12,841

-9,477

Cash flow from investing activities:
Purchases of property and equipment

352

384

5

16

17

238

466

263

140

361

664

565

578

2,733

1,077

1,836

497

Proceeds from the sale of property and equipment

15

0

0

0

0

8

1

40

0

-

-

-

-

-

-

-

-

Purchase of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

75

Net cash used in investing activities

-337

-384

-5

-16

-17

-230

-465

-223

-140

-343

-656

-565

-578

-2,733

-1,076

-1,837

-572

Cash flow from financing activities:
Cash flow from financing activities:
Proceeds from issuance of common stock and pre-funded warrants, net of underwriting fees and commissions

12,577

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of common stock warrants

2,880

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock under common stock purchase agreement

442

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock, net of underwriting fees and commissions

-

-

-

-

-

-

0

0

35,625

-

-

-

-

-

-

-

-

Payments related to public offering costs

26

0

0

0

0

-1

0

26

296

-

-

-

-

1,710

297

224

959

Payments of offering costs related to new registration statement

25

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

0

59

0

0

10

2

16

5

37

14

33

13

21

1

0

0

34

Payments on capital lease obligation

-

-

-

-

-

3

3

3

2

3

2

3

2

2

2

1

2

Net cash provided by financing activities

15,848

545

261

25,000

10

0

13

-24

35,364

-128

11

10

19

-1,775

47,443

-432

-927

Net increase (decrease) in cash, cash equivalents and restricted cash

8,073

-8,294

-10,239

26,168

-2,117

-3,979

-8,811

-7,116

25,576

-8,436

-8,107

-11,021

-4,523

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-21,053

36,062

-15,110

-10,976

Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment with accounts payable and accrued expenses

6

55

24

-69

69

-84

-238

131

191

-25

-456

164

397

-303

389

117

217

Deferred offering costs in accounts payable and accrued expenses

152

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash addition to deferred offering costs

-

-

-

-

-

-

-

-

25

-

-

-

-

-

-

-

-

Non-cash addition to facility financing obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,656

1,968

3,223

Non-cash addition to deferred offering costs

-

-

-

-

-

-

-

-

25

-

-

-

-

-

871

214

625

Deferred offering costs reclassified to additional paid-in capital

16

0

0

0

0

0

0

0

431

-

-

-

-

-

-

-

-

Reconciliation to condensed consolidated balance sheets: